Yield10 Bioscience, Inc.

  • Market Cap: N/A
  • Industry: Chemicals & Petrochemicals
  • ISIN: US98585K8624
USD
0.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Yield10 Bioscience, Inc. stock-summary
stock-summary
Yield10 Bioscience, Inc.
Chemicals & Petrochemicals
Yield10 Bioscience, Inc., formerly Metabolix, Inc., is an agricultural bioscience company. The Company is focused on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, the Company is advancing several yield traits it has developed in crops, such as Camelina, canola, soybean and corn. The Company concentrates on technologies that enables it to improve carbon dioxide fixation efficiency in photosynthesis and its direction to and conversion into plant matter. The Company has an additional agricultural science facility with greenhouses in Saskatoon, Saskatchewan, Canada.
Company Coordinates stock-summary
Company Details
19 Presidential Way Ste 201 , WOBURN MA : 01801-1184
stock-summary
Tel: 1 617 5831700
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 2 Schemes (1.09%)

Foreign Institutions

Held by 3 Foreign Institutions (0.11%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Robert Van Nostrand
Chairman of the Board, Independent Director
Dr. Oliver Peoples
President, Chief Executive Officer, Director
Dr. Sherri Brown
Director
Dr. Richard Hamilton
Director
Mr. Joseph Shaulson
Director
Dr. Anthony Sinskey
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2024)
Net Profit:
-3 Million
stock-summary
Industry

Chemicals & Petrochemicals

stock-summary
Market cap

USD 0 Million ()

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.15

stock-summary
Return on Equity

203.62%

stock-summary
Price to Book

0.00